Related references
Note: Only part of the references are listed.Biomarkers predictive of venous thromboembolism in patients with newly diagnosed high-grade gliomas
Johannes Thaler et al.
NEURO-ONCOLOGY (2014)
Perioperative thromboprophylaxis in patients with craniotomy for brain tumours: a systematic review
Andrea Salmaggi et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors
Kaisorn L. Chaichana et al.
NEUROLOGICAL RESEARCH (2013)
Intratumoral tissue factor expression and risk of venous thromboembolism in brain tumor patients
Johannes Thaler et al.
THROMBOSIS RESEARCH (2013)
Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir et al.
JAMA INTERNAL MEDICINE (2013)
Thromboembolic disease in patients with high-grade glioma
James R. Perry
NEURO-ONCOLOGY (2012)
Risk assessment for cancer-associated thrombosis: What is the best approach?
Alok A. Khorana
THROMBOSIS RESEARCH (2012)
Venous thromboembolism in malignant gliomas
E. O. Jenkins et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
PRODIGE: a randomized placebo-controlled trial of dalteparin low-molecular-weight heparin thromboprophylaxis in patients with newly diagnosed malignant glioma
J. R. Perry et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Systematic review on the effect of glucocorticoid use on procoagulant, anti-coagulant and fibrinolytic factors
B. van Zaane et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)
Assessing Risk of Venous Thromboembolism in the Patient With Cancer
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients
Stephanie L. Perry et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Development and validation of a predictive model for chemotherapy-associated thrombosis
Alok A. Khorana et al.
BLOOD (2008)
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial
H. Ian Robins et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
The coagulation system in endocrine disorders: a narrative review
A. Squizzato et al.
INTERNAL AND EMERGENCY MEDICINE (2007)
Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom
Consuelo Huerta et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Effects of the chemotherapeutic agent doxorubicin on the protein C anticoagulant pathway
Joel Woodley-Cook et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces
N Paredes et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients
BC Kuenen et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Share Paper
